ARTL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 18:48):

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system...

Stats
Šios dienos apimtis	5 102.00
Vidutinė apimtis	14 977.00
Rinkos kapitalizacija	4.38M
EPS	$0 ( 2024-03-29 )
Kita pelno data	( $-1.050 ) 2024-06-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430
ATR14	$0.0210 (1.60%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	Favorito Tamara A	Buy	2 000	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Buy	1 083	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Buy	667	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Sell	1 083	Stock Option (right to buy)
2024-02-28	Favorito Tamara A	Sell	2 000	Stock Option (right to buy)

INSIDER POWER
15.97
Last 100 transactions
Buy: 2 033 762 \| Sell: 346 866

Artelo Biosciences Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
CENT	0.916
RLAY	0.912
KNTE	0.907
GOODO	0.905
CENTA	0.897
SLDP	0.895
VERB	0.889
CSTR	0.884
CDW	0.881
NTRS	0.879

10 Labiausiai neigiamai susiję koreliacijos
NOVV	-0.898
ASLN	-0.887
SOUN	-0.86
QRTEP	-0.857
LTRY	-0.853
RPHM	-0.851
XOG	-0.85
OMER	-0.85
DHC	-0.846
ZGNX	-0.845

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Artelo Biosciences Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-3.49

FY	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-3.49

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.400

FY	2020
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-1.260

Financial Reports:

No articles found.

Artelo Biosciences Inc

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.